Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III herpes zoster gE/AS01B vaccine trial in adult autologous hematopoietic stem cell transplant recipients
NL-OMON41283Phase 3Active, not recruiting
- Sponsor
- GSK
- Start
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing Herpes zoster gE/AS01B candidate vaccine with Placebo (2 arms). Primary endpoint: Occurrence of confirmed herpes zoster cases. Started Dec 2013; status: active, not recruiting.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NL-OMON41283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41283.